Narayana Hrudayalaya (NSEI:NH) - Aktienkurs, Nachrichten und Analyse

Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

NH Aktienübersicht

Narayana Hrudayalaya Limited bietet medizinische und gesundheitliche Dienstleistungen in Indien und international an.

NH fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	3/6
Past Performance	4/6
Financial Health	6/6
Dividends	3/6

Belohnungen

Das Kurs-Gewinn-Verhältnis (30.6x) liegt unter dem Branchendurchschnitt Healthcare (42.3x)

Prognostiziertes Gewinnwachstum 9.2% pro Jahr

Die Erträge stiegen im vergangenen Jahr um 30.2%

Im Vergleich zu Wettbewerbern und der Branche gut bewertet

Risikoanalyse

Hoher Anteil an nicht zahlungswirksame Erträge

Unbeständige Dividendenentwicklung

Narayana Hrudayalaya Limited Wettbewerber

Global Health

NSEI:MEDANTA

₹320.0b

Krishna Institute of Medical Sciences

NSEI:KIMS

₹146.1b

Fortis Healthcare

NSEI:FORTIS

₹358.7b

Rainbow Children's Medicare

NSEI:RAINBOW

₹132.0b

Preisentwicklung & Leistung

Summary of all time highs, changes and price drops for Narayana Hrudayalaya
Historical stock prices
Current Share Price	₹1,189.25
52 Week High	₹1,444.90
52 Week Low	₹895.00
Beta	0.39
1 Month Change	-4.83%
3 Month Change	-9.05%
1 Year Change	27.49%
3 Year Change	140.35%
5 Year Change	427.85%
Change since IPO	252.95%

Aktuelle Nachrichten und Updates

Impressive Earnings May Not Tell The Whole Story For Narayana Hrudayalaya (NSE:NH)

Jun 01

Narayana Hrudayalaya (NSE:NH) Is Very Good At Capital Allocation

Apr 09

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

Mar 20

Recent updates

Impressive Earnings May Not Tell The Whole Story For Narayana Hrudayalaya (NSE:NH)

Jun 01

Narayana Hrudayalaya (NSE:NH) Is Very Good At Capital Allocation

Apr 09

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

Mar 20

If EPS Growth Is Important To You, Narayana Hrudayalaya (NSE:NH) Presents An Opportunity

Mar 04

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

Dec 20

Does Narayana Hrudayalaya (NSE:NH) Have A Healthy Balance Sheet?

Dec 05

We Think Narayana Hrudayalaya (NSE:NH) Might Have The DNA Of A Multi-Bagger

Nov 08

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today

Oct 21

Narayana Hrudayalaya (NSE:NH) Could Easily Take On More Debt

Aug 01

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today

Jul 07

The Trend Of High Returns At Narayana Hrudayalaya (NSE:NH) Has Us Very Interested

Jun 22

With EPS Growth And More, Narayana Hrudayalaya (NSE:NH) Makes An Interesting Case

Jan 19

We Think Shareholders Will Probably Be Generous With Narayana Hrudayalaya Limited's (NSE:NH) CEO Compensation

Aug 20

Narayana Hrudayalaya's (NSE:NH) Returns On Capital Are Heading Higher

Aug 07

Is Narayana Hrudayalaya (NSE:NH) Using Too Much Debt?

Dec 10

Aktionärsrenditen

	NH	IN Healthcare	IN Markt
7D	-5.1%	-1.4%	-1.9%
1Y	27.5%	39.8%	41.0%

Rendite im Vergleich zur Industrie: NH unter dem Niveau der Branche Indian Healthcare, die im vergangenen Jahr eine Rendite von 45.2% erzielte.

Rendite vs. Markt: NH hinter dem Markt Indian zurück, der im vergangenen Jahr eine Rendite von 45 erzielte.

Preisvolatilität

Is NH's price volatile compared to industry and market?
NH volatility
NH Average Weekly Movement	4.8%
Healthcare Industry Average Movement	5.9%
Market Average Movement	6.4%
10% most volatile stocks in IN Market	9.5%
10% least volatile stocks in IN Market	4.2%

Stabiler Aktienkurs: NH hatte in den letzten 3 Monaten keine nennenswerte Preisvolatilität.

Volatilität im Zeitverlauf: NHDie wöchentliche Volatilität (5%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
2000	11,923	Emmanuel Rupert	www.narayanahealth.org

Narayana Hrudayalaya Limited bietet medizinische und gesundheitliche Dienstleistungen in Indien und international an. Das Unternehmen erwirbt, besitzt und betreibt Krankenhäuser, Kliniken, Gesundheitszentren und Pflegeheime. Es bietet Dienstleistungen in den Bereichen Kardiologie, Herzchirurgie, Nephrologie, Urologie, Neurologie, Neurochirurgie, Endokrinologie, Orthopädie, innere Medizin, Geburtshilfe, Gynäkologie, Pädiatrie, Neonatologie, Gastroenterologie und Onkologie an.

Narayana Hrudayalaya Limited's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Narayana Hrudayalaya im Vergleich zum Marktanteil des Unternehmens?
NH grundlegende Statistiken
Marktanteil	₹241.50b
Gewinn(TTM)	₹7.89b
Umsatz(TTM)	₹50.18b

30.6x

Kurs-Gewinn-Verhältnis

4.8x

Kurs-Umsatz-Verhältnis

Ist NH zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
NH Gewinn- und Verlustrechnung (TTM)
Einnahmen	₹50.18b
Kosten der Einnahmen	₹29.63b
Bruttogewinn	₹20.55b
Sonstige Ausgaben	₹12.66b
Umsatz	₹7.89b

Zuletzt gemeldete Gewinne

Mar 31, 2024

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	38.87
Bruttomarge	40.96%
Nettogewinnspanne	15.73%
Schulden/Eigenkapital-Verhältnis	50.0%

Wie hat sich NH auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

0.3%

Aktuelle Dividendenrendite

10%

Ausschüttungsquote

Zahlt NH eine zuverlässige Dividende?

Siehe NH Dividendenhistorie und Benchmarks

Bis wann müssen Sie NH kaufen, um eine kommende Dividende zu erhalten?
Narayana Hrudayalaya Dividendentermine
Ex-Dividenden Datum	Aug 02 2024
Datum der Dividendenzahlung	Sep 29 2024
Tage bis Ex-Dividende	60 days
Tage bis zum Datum der Dividendenzahlung	118 days

Zahlt NH eine zuverlässige Dividende?

Siehe NH Dividendenhistorie und Benchmarks

NH Aktienübersicht

Belohnungen

Risikoanalyse

Narayana Hrudayalaya Limited Wettbewerber

NSEI:MEDANTA

₹320.0b

NSEI:KIMS

₹146.1b

NSEI:FORTIS

₹358.7b

NSEI:RAINBOW

₹132.0b

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Impressive Earnings May Not Tell The Whole Story For Narayana Hrudayalaya (NSE:NH)

Full year 2024 earnings: EPS and revenues miss analyst expectations

Narayana Hrudayalaya Limited Recommends Final Dividend for the Year Ended 31St March, 2024

Narayana Hrudayalaya Limited to Report Q4, 2024 Results on May 24, 2024

Narayana Hrudayalaya (NSE:NH) Is Very Good At Capital Allocation

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

Recent updates

Impressive Earnings May Not Tell The Whole Story For Narayana Hrudayalaya (NSE:NH)

Full year 2024 earnings: EPS and revenues miss analyst expectations

Narayana Hrudayalaya Limited Recommends Final Dividend for the Year Ended 31St March, 2024

Narayana Hrudayalaya Limited to Report Q4, 2024 Results on May 24, 2024

Narayana Hrudayalaya (NSE:NH) Is Very Good At Capital Allocation

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

If EPS Growth Is Important To You, Narayana Hrudayalaya (NSE:NH) Presents An Opportunity

Price target increased by 8.1% to ₹1,390

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Narayana Hrudayalaya Limited to Report Q3, 2024 Results on Feb 14, 2024

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

Does Narayana Hrudayalaya (NSE:NH) Have A Healthy Balance Sheet?

Investor sentiment improves as stock rises 16%

Consensus EPS estimates increase by 16%

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

We Think Narayana Hrudayalaya (NSE:NH) Might Have The DNA Of A Multi-Bagger

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today

Price target increased by 8.2% to ₹1,070

Consensus EPS estimates increase by 11%

Narayana Hrudayalaya Limited Approves Dividend for the Financial Year Ended March 31, 2023

Narayana Hrudayalaya Limited Announces Board Retirements, Effective August 7, 2023

Narayana Hrudayalaya (NSE:NH) Could Easily Take On More Debt

Narayana Hrudayalaya Limited to Report Q1, 2024 Results on Aug 02, 2023

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited Proposes Dividend for the Financial Year Ended March 31, 2023

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today

Upcoming dividend of ₹2.50 per share at 0.3% yield

The Trend Of High Returns At Narayana Hrudayalaya (NSE:NH) Has Us Very Interested

Price target increased by 7.5% to ₹943

Full year 2023 earnings released: EPS: ₹29.85 (vs ₹16.85 in FY 2022)

Narayana Hrudayalaya Limited, Annual General Meeting, Aug 04, 2023

Narayana Hrudayalaya Limited to Report Q4, 2023 Results on May 19, 2023

Price target increased by 7.4% to ₹878

Narayana Hrudayalaya Limited Announces Board Appointments

Narayana Hrudayalaya Limited to Report Q3, 2023 Results on Feb 08, 2023

Narayana Hrudayalaya Limited Files Application for Strike-Off of Name of Wholly Owned Subsidiary, Narayana Health Institutions Private Limited

With EPS Growth And More, Narayana Hrudayalaya (NSE:NH) Makes An Interesting Case

Insufficient new directors

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited to Report Q2, 2023 Results on Nov 09, 2022

Narayana Hrudayalaya Limited (NSEI:NH) acquired Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited.

Narayana Hrudayalaya (NSE:NH) Seems To Use Debt Rather Sparingly

Narayana Hrudayalaya Limited (NSEI:NH) signed a Business Transfer Agreement to acquire Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited for INR 2 billion.

Narayana Hrudayalaya Limited (NSEI:NH) signed a Business Transfer Agreement to acquire Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited for INR 2 billion.

Narayana Hrudayalaya Limited Approves the Dividend for the Financial Year Ended 31 March 2022

Upcoming dividend of ₹1.00 per share

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Is Well Worth Watching

Narayana Hrudayalaya Limited Proposes Dividend for the Financial Year Ended 31 March 2022

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited to Report Q1, 2023 Results on Aug 08, 2022

Narayana Health Announces Appointment of Ashish Bajaj as the Chief Marketing Officer

We Think Narayana Hrudayalaya (NSE:NH) Might Have The DNA Of A Multi-Bagger

Full year 2022 earnings: EPS misses analyst expectations

Narayana Hrudayalaya Limited Recommends Dividend for the Year Ended March 31, 2022

Price target increased to ₹729

Insufficient new directors

Insufficient new directors

Narayana Hrudayalaya Limited Announces Appointment of Viren Prasad Shetty as Executive Vice-Chairman

Returns On Capital Are A Standout For Narayana Hrudayalaya (NSE:NH)

Erträge & Einnahmen